Warrant D definition

Warrant D means the warrant issued by the Company in accordance with this Deed and all rights conferred by it, including the Subscription Rights, in respect of the Warrant D Shares;
Sample 1Sample 2Sample 3
Warrant D means the warrant issued by the Company in accordance with this Agreement and all rights conferred by it, including the subscription rights, in respect of the Warrant D Shares.
Sample 1
Warrant D means the Common Stock Purchase Warrant in the form attached hereto as Exhibit G.
Sample 1

Examples of Warrant D in a sentence

  • FG Warrant D: Total exercise price of US$1,500,000 upon successful cultivation and processing of a further 5,000 kg of GACP grade dried flower.

  • At December 31, 2020, the fair value of Warrant D has been estimated at $74,147, using a Monte Carlo Simulation with the following assumptions: (i) expected dividend yield of 0%; (ii) expected volatility of 95%; (iii) risk free interest rate of 0.35%; (iv) share price of $0.091; and (v) expected life of 3 years.

  • Preparation processes at the tissue establishments must comply with the requirements set out in Annex II.

  • At February 28, 2021, the fair value of Warrant D has been estimated at $124,156, using a Monte Carlo Simulation with the following assumptions: (i) expected dividend yield of 0%; (ii) expected volatility of 100%; (iii) risk free interest rate of 0.78%; (iv) share price of $0.13; and (v) expected life of 3 years.

  • The expected volatility is based on the historical trading prices of similar companies.At September 30, 2020, the fair value of Warrant D has been estimated at $139,814, using a Monte Carlo Simulation with the following assumptions: (i) expected dividend yield of 0%; (ii) expected volatility of 100%; (iii) risk free interest rate of 0.34%; (iv) share price of $0.117; and (v) expected life of 3 years.

  • The FG Warrants will: (a) be issued in tranches, as outlined below; (b) have a term of three (3) years; and (c) have an exercise price equal to the greater of: (i) C$0.35 with respect to FG Warrant B and C and C$0.42 with respect to FG Warrant D, E and F and (ii) the five day volume weighted average price (the “VWAP”) of MPXI on the CSE as of the day the respective milestone has been met, unless otherwise indicated below.

  • U.S. Treasury Warrant Placements Bidder institution name: Office phone: Bidder individual first name: Mobile phone Bidder individual last name: Email: # Company Ticker Expiration Ex Date P ercise rice Q Warrant D Shares T uarterlyividend hreshold Minimum Bid Price (in aggregate) Bid Price (in aggregate) 1 BBCN Bancorp, Inc.

  • The theoretical fair value for the 993,885,016 Warrants D at RM0.01 per Warrant D was recognised as a discount of issuance, by which the share capital of the Company decreases from RM144,223,262 to RM134,284,411.

  • Strictly for illustrative purposes, assuming full exercise of 902,441,557 Warrants D at the Exercise Price of RM0.18 per Warrant D, the proceeds to be raised by the Company is approximately RM162.4 million.

  • DOC Secretary Warrant D OC Warrants D esk-24/7 • 000-000-0000 Concerns after normal business hours For example: offenders under DOC supervision or issues related to DOC staff or DOC equipment D OC Warrants D esk-24 /7 War rants Desk will refer to the appropriate Duty Officer • 000-000-0000 Violator Medical Billing • Requests for reimbursement for medical care not included in the offender base rate.

Related to Warrant D

  • Warrant means this Warrant and all Warrants issued in exchange, transfer or replacement thereof.

  • Warrant Securities means this Warrant and the Warrant Shares, collectively.

  • Warrant Agreement means the Warrant Agreement, dated as of the date set forth in Item 4 of Schedule A hereto, as amended from time to time, between the Company and the United States Department of the Treasury.

  • Warrant Share Number means at any time the aggregate number of shares of Warrant Stock which may at such time be purchased upon exercise of this Warrant, after giving effect to all prior adjustments and increases to such number made or required to be made under the terms hereof.

  • Warrant Consideration has the meaning specified in Section 4(i)(i) hereof.

  • Warrant Price as used in this Agreement shall mean the price per share at which shares of Common Stock may be purchased at the time a Warrant is exercised. The Company in its sole discretion may lower the Warrant Price at any time prior to the Expiration Date (as defined below) for a period of not less than twenty (20) Business Days, provided, that the Company shall provide at least twenty (20) days prior written notice of such reduction to Registered Holders of the Warrants and, provided further that any such reduction shall be identical among all of the Warrants.

  • Warrant Purchase Agreement means a warrant purchase agreement under which a Warrant is issued entered into by Borrower and an Affiliate of Lenders contemporaneously with the execution of this Loan Agreement.

  • Warrant Agent Agreement means that certain Warrant Agent Agreement, dated as of the date hereof, between the Depositor and U.S. Bank Trust National Association, as Warrant Agent and as Trustee, as the same may be amended from time to time.

  • Common Warrant Shares means the shares of Common Stock issuable upon exercise of the Common Warrants.

  • Current Warrant Price means, in respect of a share of Common Stock at any date herein specified, the price at which a share of Common Stock may be purchased pursuant to this Warrant on such date.

  • Warrant Certificate means a certificate, substantially in the form set forth in Schedule “A” hereto, to evidence those Warrants that will be evidenced by a certificate;

  • Warrant Agreements means those agreements entered into in connection with the Loan, substantially in the form attached hereto as Exhibit B pursuant to which Borrower granted Lender the right to purchase that number of shares of Series B Preferred Stock of Borrower as more particularly set forth therein.

  • Warrant Shares means the shares of Common Stock issuable upon exercise of the Warrants.

  • New Warrant Agreement means that certain agreement providing for, among other things, the issuance and terms of the New Warrants issued by New Valaris Holdco as set forth in the Restructuring Term Sheet.

  • Warrant Stock means Common Stock issuable upon exercise of any Warrant or Warrants or otherwise issuable pursuant to any Warrant or Warrants.

  • this Warrant means, collectively, this Warrant and all other stock purchase warrants issued in exchange therefor or replacement thereof.

  • Warrant Exercise Price means $0.01 per share.

  • Warrant Purchase Price shall have the meaning ascribed to such term in Section 2.1(b).

  • Call Warrant As defined in the recitals.

  • holder of a Warrant Certificate as used herein shall mean any person in whose name at the time any Warrant Certificate shall be registered upon the books to be maintained by the Warrant Agent for that purpose.

  • Warrant Exercise Period shall commence (subject to Section 6(d) below), on the later of:

  • Warrant Value means the fair value of all warrants, options and other similar rights issued to a third party in connection with an Other Financing, determined by using a standard Black-Scholes option-pricing model using an expected volatility percentage as shall be mutually agreed by the Investor and the Company. In the case of a dispute relating to such expected volatility assumption, the Investor shall obtain applicable volatility data from three investment banking firms of nationally recognized reputation, and the parties hereto shall use the average thereof for purposes of determining the expected volatility percentage in connection with the Black-Scholes calculation referred to in the immediately preceding sentence. EXHIBIT A TO THE COMMON STOCK PURCHASE AGREEMENT FORM OF FIXED REQUEST NOTICE Reference is made to the Common Stock Purchase Agreement dated as of November 8, 2011, (the “Purchase Agreement”) between Arena Pharmaceuticals, a corporation organized and existing under the laws of the State of Delaware (the “Company”), and Azimuth Opportunity, L.P., an international limited partnership organized under the laws of the British Virgin Islands. Capitalized terms used and not otherwise defined herein shall have the meanings given such terms in the Purchase Agreement. In accordance with and pursuant to Section 2.1 of the Purchase Agreement, the Company hereby issues this Fixed Request Notice to exercise a Fixed Request for the Fixed Amount Requested indicated below. Fixed Amount Requested: Optional Amount Dollar Amount: Pricing Period start date: Pricing Period end date: Settlement Date: Fixed Request Threshold Price: Optional Amount Threshold Price: Dollar Amount of Common Stock Currently Unissued under the Registration Statement; Dollar Amount of Common Stock Currently Available under the Aggregate Limit: Dated: By: Name Title: Address: Facsimile No. AGREED AND ACCEPTED By: Name Title: EXHIBIT B TO THE COMMON STOCK PURCHASE AGREEMENT FORM OF OPTIONAL AMOUNT NOTICE To: Fax#: Reference is made to the Common Stock Purchase Agreement dated as of November 8, 2011 (the “Purchase Agreement”) between Arena Pharmaceuticals, Inc., a corporation organized and existing under the laws of the State of Delaware (the “Company”), and Azimuth Opportunity, L.P., an international limited partnership organized under the laws of the British Virgin Islands (the “Investor”). Capitalized terms used and not otherwise defined herein shall have the meanings given such terms in the Purchase Agreement. In accordance with and pursuant to Section 2.11 of the Purchase Agreement, the Investor hereby issues this Optional Amount Notice to exercise an Optional Amount for the Optional Amount Dollar Amount indicated below. Optional Amount Dollar Amount Exercised Number of Shares to be purchased VWAP on the date hereof: Discount Price: Settlement Date: Threshold Price: Dated: By: Name Title: Address: Facsimile No. EXHIBIT C TO THE COMMON STOCK PURCHASE AGREEMENT CERTIFICATE OF THE COMPANY CLOSING CERTIFICATE The undersigned, the [ ] of Arena Pharmaceuticals, Inc., a corporation organized and existing under the laws of the State of Delaware (the “Company”), delivers this certificate in connection with the Common Stock Purchase Agreement, dated as of November 8, 2011 (the “Agreement”), by and between the Company and Azimuth Opportunity, L.P., an international limited partnership organized under the laws of the British Virgin Islands (the “Investor”), and hereby certifies on the date hereof that (capitalized terms used herein without definition have the meanings assigned to them in the Agreement):

  • Warrant Share Delivery Date shall have the meaning set forth in Section 2(d)(i).

  • Warrantholder has the meaning set forth in Section 2.

  • Warrant Coverage means 2.95% times the aggregate principal amount of Term Loan Advances (as defined in the Loan Agreement) made and funded under the Loan Agreement on the Effective Date.

  • Warrant Documents means the Warrant Instrument, the Warrants and the Registration Rights Agreement.